Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Albert Bourla
Pharma
More reductions for Pfizer as it tacks on $2.5B in cost savings
Pfizer will reduce its costs by $2.5 billion in another round of cutbacks that will begin next year and run through 2029.
Kevin Dunleavy
Aug 4, 2026 11:33am
Pfizer CEO Bourla reconsiders future German investments: Reuters
Jun 10, 2026 11:26am
At ASCO, China biotech industry cements its coming of age
Jun 3, 2026 8:50am
Pfizer CEO Albert Bourla earns 2025 pay bump to $27.6M
Mar 13, 2026 11:26am
Pfizer CEO Albert Bourla levels criticism of CBER's Vinay Prasad
Mar 3, 2026 4:58pm
Pfizer CEO blasts RFK Jr. over 'anti-science' vaccine stance: WSJ
Jan 21, 2026 11:01am
